ONESOURCE SPECIALTY PHARMA
|
The Current P/E Ratio of ONESOURCE SPECIALTY PHARMA is -50.40.
Share Price | ₹1,587.4 | Apr 02,2025 |
Market Cap | ₹18,159.3 Cr | |
Earnings-TTM | ₹-360.3 Cr | TTM-Standalone Results |
Price/Earnings | -50.40x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ONESOURCE SPECIALTY PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹18,159.3 Cr] as on Apr 02,2025
(/) Earnings [ ₹-360.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -50.40x ]
Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay -50.40 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ONESOURCE SPECIALTY PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of ONESOURCE SPECIALTY PHARMA
PE Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA
- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending to Apr 02,2025 averaged nanx.
- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of x from fiscal years ending March 2018 to 2022.
- Looking back at the last 0 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in at x.
- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in of x.
How does ONESOURCE SPECIALTY PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ONESOURCE SPECIALTY PHARMA | -360.33 | -50.40 | 18,159.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.81 | 411,306.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 72.73 | 150,343.0 |
CIPLA LTD | 5,000.43 | 23.46 | 117,323.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 58.33 | 108,619.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.67 | 95,941.5 |
MANKIND PHARMA LTD | 2,050.73 | 48.71 | 99,891.5 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.53 | 89,680.6 |
LUPIN LTD | 2,892.10 | 31.72 | 91,742.2 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.23 | 67,294.6 |
ABBOTT INDIA LTD | 1,334.46 | 47.09 | 62,839.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ONESOURCE SPECIALTY PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -50.40x |
Max industry PE | 72.73x |
Median industry PE | 31.72x |
Average industry PE | 29.44x |
You may also like the below Video Courses